Health Canada Approves Abbott's XIENCE V(R) Drug Elu...(XIENCE V drug eluting stent is marketed ...),Health

Date:8/24/2009

XIENCE V drug eluting stent is marketed in the United States, Europe and other international markets. XIENCE V is an investigational device in Japan and is currently under review by Japan's Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency.

Abbott supplies a private-labeled XIENCE V to Boston Scientific called the PROMUS(TM) Everolimus-Eluting Coronary Stent System. PROMUS is manufactured by Abbott and supplied to Boston Scientific as part of a distribution agreement between the two companies.

Everolimus, developed by Novartis Pharma AG, is a proliferation signal inhibitor, or mTOR inhibitor, licensed to Abbott by Novartis for use on its drug eluting stents. Everolimus has been shown to inhibit in-stent neointimal growth in the coronary vessels following stent implantation, due to its anti-proliferative properties.

XIENCE V is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (lesions < / = 28 mm) with reference vessel diameters of 2.5 mm to 4.25 mm. Additional information about XIENCE V, including important safety information, is available online at www.xiencev.com or www.abbottvascular.com/en_US/content/document/eIFU_XienceV.pdf.

About Abbott Vascular

Abbott Vascular, a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is uniquely focused on advancing the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medici
'/>"/>

SOURCE Abbott Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Emdeon and BroMenn Healthcare System Take the Lead on Consumer Price Transparency
2. Baylor University Economists Call for Different Tack on Health Care Insurance
3. LifeCare Solutions Simplifies Healthcare Order Process Management with Authentidates Inscrybe Healthcare
4. BryanLGH Health System Selects Clinical Xpert From Thomson Reuters to Improve Clinical Quality
5. Mom & Baby Mobile Health Centers Have Become Primary Care Providers Along the Gulf Coast
6. eHealth interventions need to be continuously evaluated
7. Harvard study reveals taxing job-based health benefits would hit working families hardest
8. Symmetry Medical to Present at Thomas Weisel Partners 2009 Healthcare Conference
9. New Study of House Health Reform Bill: Minnesota Faces Over $654 Million in Medicare-Funded Nursing Home Cuts Over Ten Years
10. U.S. Senate Candidate Cheryle Jackson: Public Option Critical to Real Health Care Reform
11. Healthcare: Public Option Mirrors Other Government Insurance Plans